Apimeds Pharmaceuticals US (APUS) Capital Expenditures (2025)
Apimeds Pharmaceuticals US (APUS) recorded Capital Expenditures of $21,424 in Q4 2025, down 5.0% from the prior quarter.
Powered by 
Analysis
Apimeds Pharmaceuticals US (APUS) Capital Expenditures (2025) Analysis & Trends
For FY2025, Apimeds Pharmaceuticals US reported Capital Expenditures of $57,333.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.61 Bn | 1,122.20 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 624.26 Bn | 542.79 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 512.23 Bn | 485.34 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.41 Bn | 319.79 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.24 Bn | 261.23 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 234.57 Bn | 189.97 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 192.81 Bn | 167.01 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 5.65 Mn | -13.98 Mn | - | - |
API Access
Apimeds Pharmaceuticals US Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=APUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "APUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=APUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();